Tse Kiat Soong, Sarah Shuyun Tang, Yi Xun Lim, Ngiam Kee Yuan, James Wai Kit Lee, Rajeev Parameswaran
{"title":"甲状腺癌中受累喉返神经的处理。","authors":"Tse Kiat Soong, Sarah Shuyun Tang, Yi Xun Lim, Ngiam Kee Yuan, James Wai Kit Lee, Rajeev Parameswaran","doi":"10.1159/000548260","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recurrent laryngeal nerve palsy (RLNP) is not uncommon after thyroid surgery and can be debilitating. This is a retrospective cohort analysis of outcomes in patients with RLNP post-thyroidectomy for differentiated thyroid malignancy.</p><p><strong>Method: </strong>Clinicopathological details as well as outcomes of thyroidectomies for differentiated thyroid cancer in 862 patients performed over a period of 22 years (2001-2023) for nerve palsy were collected. The patients were stratified into two groups based on whether the recurrent laryngeal nerve (RLN) was amputated or preserved.</p><p><strong>Results: </strong>Of the 1520 nerves in 862 patients at risk during thyroidectomy, a total of 71 (8.2%) (20M:51F) patients, with a median age of 54 (range: 19 - 83) suffered RLNP, which was temporary in 14 (1.6%), unilateral in 51 (5.9%) and bilateral in 6 (0.7%) patients. The RLN was amputated in 31 of 62 patients (50%). In 29 of 71(41%) patients the nerve was intentionally sacrificed due to gross disease infiltration while the RLN was inadvertently severed during dissection in 2 (3%) patients. Among cases with recurrent laryngeal nerve (RLN) transection, only five underwent primary repair or ansa cervicalis to RLN anastomosis. The only factor associated with amputation of the RLN was a larger tumour size (40.4 vs 24.7mm, p = 0.007). Preservation of voice quality was higher in the shave group in comparison to the amputation group ((93.5% vs 71.0%, p = 0.0426).</p><p><strong>Conclusion: </strong>Preservation of nerve or reconstruction in transectional injuries should be considered where possible to improve voice outcomes except in cases when the laryngotracheal complex is involved.</p>","PeriodicalId":19497,"journal":{"name":"Oncology","volume":" ","pages":"1-17"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Managing the involved recurrent laryngeal nerve in thyroid cancer.\",\"authors\":\"Tse Kiat Soong, Sarah Shuyun Tang, Yi Xun Lim, Ngiam Kee Yuan, James Wai Kit Lee, Rajeev Parameswaran\",\"doi\":\"10.1159/000548260\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Recurrent laryngeal nerve palsy (RLNP) is not uncommon after thyroid surgery and can be debilitating. This is a retrospective cohort analysis of outcomes in patients with RLNP post-thyroidectomy for differentiated thyroid malignancy.</p><p><strong>Method: </strong>Clinicopathological details as well as outcomes of thyroidectomies for differentiated thyroid cancer in 862 patients performed over a period of 22 years (2001-2023) for nerve palsy were collected. The patients were stratified into two groups based on whether the recurrent laryngeal nerve (RLN) was amputated or preserved.</p><p><strong>Results: </strong>Of the 1520 nerves in 862 patients at risk during thyroidectomy, a total of 71 (8.2%) (20M:51F) patients, with a median age of 54 (range: 19 - 83) suffered RLNP, which was temporary in 14 (1.6%), unilateral in 51 (5.9%) and bilateral in 6 (0.7%) patients. The RLN was amputated in 31 of 62 patients (50%). In 29 of 71(41%) patients the nerve was intentionally sacrificed due to gross disease infiltration while the RLN was inadvertently severed during dissection in 2 (3%) patients. Among cases with recurrent laryngeal nerve (RLN) transection, only five underwent primary repair or ansa cervicalis to RLN anastomosis. The only factor associated with amputation of the RLN was a larger tumour size (40.4 vs 24.7mm, p = 0.007). Preservation of voice quality was higher in the shave group in comparison to the amputation group ((93.5% vs 71.0%, p = 0.0426).</p><p><strong>Conclusion: </strong>Preservation of nerve or reconstruction in transectional injuries should be considered where possible to improve voice outcomes except in cases when the laryngotracheal complex is involved.</p>\",\"PeriodicalId\":19497,\"journal\":{\"name\":\"Oncology\",\"volume\":\" \",\"pages\":\"1-17\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000548260\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000548260","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:喉返神经麻痹(RLNP)在甲状腺手术后并不罕见,可使人衰弱。这是一项对分化性甲状腺恶性肿瘤甲状腺切除术后RLNP患者预后的回顾性队列分析。方法:收集2001-2023年间862例因神经性麻痹而行分化型甲状腺癌切除术的临床病理资料及治疗结果。根据喉返神经(RLN)是否切除或保留,将患者分为两组。结果:在862例甲状腺切除术高危患者的1520条神经中,共有71例(8.2%)(20M:51F)患者发生RLNP,中位年龄54岁(19 ~ 83岁),其中暂时性14例(1.6%),单侧51例(5.9%),双侧6例(0.7%)。62例患者中有31例(50%)切除了RLN。71例患者中有29例(41%)因疾病浸润而有意牺牲神经,2例(3%)患者在解剖过程中无意切断RLN。在喉返神经(RLN)横断的病例中,只有5例接受了初级修复或颈袢与RLN吻合。与RLN截肢相关的唯一因素是肿瘤大小较大(40.4 vs 24.7mm, p = 0.007)。与截肢组相比,剃须组的语音质量保存更高(93.5% vs 71.0%, p = 0.0426)。结论:在横断性损伤中,除了涉及喉-气管复合体的情况外,应考虑保留神经或重建神经以改善语音预后。
Managing the involved recurrent laryngeal nerve in thyroid cancer.
Background: Recurrent laryngeal nerve palsy (RLNP) is not uncommon after thyroid surgery and can be debilitating. This is a retrospective cohort analysis of outcomes in patients with RLNP post-thyroidectomy for differentiated thyroid malignancy.
Method: Clinicopathological details as well as outcomes of thyroidectomies for differentiated thyroid cancer in 862 patients performed over a period of 22 years (2001-2023) for nerve palsy were collected. The patients were stratified into two groups based on whether the recurrent laryngeal nerve (RLN) was amputated or preserved.
Results: Of the 1520 nerves in 862 patients at risk during thyroidectomy, a total of 71 (8.2%) (20M:51F) patients, with a median age of 54 (range: 19 - 83) suffered RLNP, which was temporary in 14 (1.6%), unilateral in 51 (5.9%) and bilateral in 6 (0.7%) patients. The RLN was amputated in 31 of 62 patients (50%). In 29 of 71(41%) patients the nerve was intentionally sacrificed due to gross disease infiltration while the RLN was inadvertently severed during dissection in 2 (3%) patients. Among cases with recurrent laryngeal nerve (RLN) transection, only five underwent primary repair or ansa cervicalis to RLN anastomosis. The only factor associated with amputation of the RLN was a larger tumour size (40.4 vs 24.7mm, p = 0.007). Preservation of voice quality was higher in the shave group in comparison to the amputation group ((93.5% vs 71.0%, p = 0.0426).
Conclusion: Preservation of nerve or reconstruction in transectional injuries should be considered where possible to improve voice outcomes except in cases when the laryngotracheal complex is involved.
期刊介绍:
Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.